248 related articles for article (PubMed ID: 4038033)
1. Calcitonin therapy in prolonged immobilization hypercalcemia.
Carey DE; Raisz LG
Arch Phys Med Rehabil; 1985 Sep; 66(9):640-4. PubMed ID: 4038033
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate.
Meythaler JM; Tuel SM; Cross LL
Arch Phys Med Rehabil; 1993 Mar; 74(3):316-9. PubMed ID: 8439262
[TBL] [Abstract][Full Text] [Related]
3. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
Meythaler JM; Korkor AB; Nanda T; Kumar NA; Fallon M
Arch Intern Med; 1986 Aug; 146(8):1567-71. PubMed ID: 3089187
[TBL] [Abstract][Full Text] [Related]
4. Immobilization hypercalcemia in spinal cord injury.
Maynard FM; Imai K
Arch Phys Med Rehabil; 1977 Jan; 58(1):16-24. PubMed ID: 831659
[TBL] [Abstract][Full Text] [Related]
5. [Medical treatment of malignant hypercalcemia].
Eto S; Nakano Y; Okada Y
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
[TBL] [Abstract][Full Text] [Related]
6. Immobilization hypercalcemia following spinal cord injury.
Maynard FM
Arch Phys Med Rehabil; 1986 Jan; 67(1):41-4. PubMed ID: 2935120
[TBL] [Abstract][Full Text] [Related]
7. Human synthetic calcitonin therapy for hypercalcemia of immobilization.
Kaul S; Sockalosky JJ
J Pediatr; 1995 May; 126(5 Pt 1):825-7. PubMed ID: 7752017
[TBL] [Abstract][Full Text] [Related]
8. Spinal cord injury hypercalcemia: therapeutic profile.
Claus-Walker J; Halstead LS; Rodriguez GP; Henry YK
Arch Phys Med Rehabil; 1982 Mar; 63(3):108-15. PubMed ID: 6803736
[TBL] [Abstract][Full Text] [Related]
9. [Hypercalcemia due to immobilization in critically ill children: calcitnonin treatment].
Urán Moreno M; Alonso Riofrío R; Moliner Robredo C; Pons Morales S; López-Herce Cid J
An Esp Pediatr; 2001 Jun; 54(6):555-8. PubMed ID: 11412402
[TBL] [Abstract][Full Text] [Related]
10. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
11. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
[TBL] [Abstract][Full Text] [Related]
12. Effect of pamidronate in a rat hypercalcemia model induced by cholecalciferol.
Okada M; Noguchi S; Hasegawa Y; Inukai T
Arzneimittelforschung; 1992 Apr; 42(4):543-6. PubMed ID: 1322674
[TBL] [Abstract][Full Text] [Related]
13. Combined calcitonin and oral phosphate treatment for hypercalcemia in multiple myeloma.
Brautbar N; Luboshitzky R
Arch Intern Med; 1977 Jul; 137(7):914-6. PubMed ID: 879932
[TBL] [Abstract][Full Text] [Related]
14. Immobilization hypercalcemia in acute spinal cord injury treated with etidronate.
Merli GJ; McElwain GE; Adler AG; Martin JH; Roberts JD; Schnall B; Ditunno JF
Arch Intern Med; 1984 Jun; 144(6):1286-8. PubMed ID: 6428341
[TBL] [Abstract][Full Text] [Related]
15. Severe immobilization hypercalcemia, renal insufficiency, and calcification.
Conley SB; Shackelford GD; Robson AM
Pediatrics; 1979 Jan; 63(1):142-5. PubMed ID: 440790
[TBL] [Abstract][Full Text] [Related]
16. Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy.
Binstock ML; Mundy GR
Ann Intern Med; 1980 Aug; 93(2):269-72. PubMed ID: 7406378
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology and management of severe hypercalcemia.
Nussbaum SR
Endocrinol Metab Clin North Am; 1993 Jun; 22(2):343-62. PubMed ID: 8325291
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hypercalcemia.
Attie MF
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):807-28. PubMed ID: 2673775
[TBL] [Abstract][Full Text] [Related]
19. Immobilization hypercalcemia: a case report and review of the literature.
Wolf AW; Chuinard RG; Riggins RS; Walter RM; Depner T
Clin Orthop Relat Res; 1976; (118):124-9. PubMed ID: 133782
[TBL] [Abstract][Full Text] [Related]
20. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
